BBT Capital Management’s Zimmer Biomet ZBH Stock Holding History

BBT Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,452	Closed	-$280K	–	145
2019 Q2	$280K	Buy	2,452 +632	+35%	+$74K	0.33%	124
2019 Q1	$226K	Buy	+1,820	New	+$207K	0.28%	117
2016 Q1	–	Sell	-77,250	Closed	-$7.69M	–	104
2015 Q4	$7.69M	Hold	77,250	–	–	0.91%	36
2015 Q3	$7.04M	Hold	77,250	–	–	0.66%	53
2015 Q2	$8.19M	Hold	77,250	–	–	0.75%	50
2015 Q1	$8.81M	Hold	77,250	–	–	0.9%	38
2014 Q4	$8.51M	Hold	77,250	–	–	0.71%	41
2014 Q3	$7.54M	Buy	+77,250	New	+$7.6M	0.41%	68

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBT Capital Management's ZBH Position: Q3 2019 in Review

BBT Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2019, closing a stake of 2,452 shares — an estimated $280K sold.

BBT Capital Management first reported a position in ZBH in Q3 2014 and held it in 8 quarters. The position peaked at $8.81M in Q1 2015. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

BBT Capital Management reported no remaining Zimmer Biomet position as of Q3 2019 after selling out during the quarter.
BBT Capital Management sold 2,452 Zimmer Biomet shares in Q3 2019, an estimated $280K.
BBT Capital Management first reported a position in Zimmer Biomet in Q3 2014 and held it in 8 quarters.
BBT Capital Management's Zimmer Biomet position peaked at $8.81M in Q1 2015.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on BBT Capital Management's 13F filing for Q3 2019.